Capital Flow Monitor · Sponsors · CIK 1669498
Turtle Creek Canadian Equity Fund
Scotia Plaza, Toronto, A6, M5H 3Y2 · 416-365-7400
Pooled Investment Fund / Other Investment Fund · Other· inc. ONTARIO, CANADA true
Fit score
—
Offering
—
Sold
$0
% sold
—
Investors
0
Min investment
$2.0M
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-21 | D/A ·current | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
| 2025-07-21 | D/A | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
n/a Turtle Creek Asset Management Inc. — Executive Officer, Toronto, A6
5 other raises
- Turtle Creek United States Equity Fund $600K of —
- Turtle Creek Synthetic PE Fund $400K of —
- Turtle Creek Investment Fund $10.7M of —
- Turtle Creek Equity U.S. Feeder LP $27.9M of —
- Turtle Creek Equity Fund $48.9M of —
-
Andrew Brenton — Executive Officer / Director, Toronto, A6
5 other raises
- Turtle Creek United States Equity Fund $600K of —
- Turtle Creek Synthetic PE Fund $400K of —
- Turtle Creek Investment Fund $10.7M of —
- Turtle Creek Equity U.S. Feeder LP $27.9M of —
- Turtle Creek Equity Fund $48.9M of —
-
Jeffrey Cole — Executive Officer / Director, Toronto, A6
6 other raises
- Turtle Creek United States Equity Fund $600K of —
- Turtle Creek Synthetic PE Fund $400K of —
- Turtle Creek Investment Fund $10.7M of —
- Turtle Creek Equity U.S. Feeder LP $27.9M of —
- Turtle Creek Equity Fund $48.9M of —
- Cadrenal Therapeutics, Inc. $8.8M of $8.8M · 100.0%
-
Jeffrey Hebel — Executive Officer / Director, Toronto, A6
5 other raises
- Turtle Creek United States Equity Fund $600K of —
- Turtle Creek Synthetic PE Fund $400K of —
- Turtle Creek Investment Fund $10.7M of —
- Turtle Creek Equity U.S. Feeder LP $27.9M of —
- Turtle Creek Equity Fund $48.9M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.